Stock-market dispatch — 2026-08-06

Headless run (Thu). Research output, not advice — brain never trades. Marks are live 08-06 intraday twelvedata quotes; 51/51 priced, 0 429s. Weekly ledger (4d) not due (last full run Fri 07-31; next ~Fri 08-07). Supabase upsert + push are performed by the wrapper, not this run. Podcast vein dark for a 2nd day — now for two independent reasons (see log).

Top of mind

The first live-feedback calibration since the gate was built — and it fired on a chain whose fundamentals are fine. pwr-transformer-moat-to-eps-doubling is medium-high (0.73) on a well-traced chain that beat on 07-30 (record $53B backlog, HICO breakers, FY EPS $16.45–16.95). Its live paper sector-excess is −10.7% — wider than the −9.5% of 08-05. What makes today different from the seven prior breaches is that this ledger made a prediction on 07-31 and it failed: the gate was "acknowledged, not fired" then, on the explicit reasoning that the mark predated the beat and "today's beat swings PWR's sector-excess sharply positive next mark." Six days and a +17.3% pop later it is wider. A record backlog that produces no sector outperformance is evidence the moat is already in the sector multiple. /calibrate logged (overconfidence/favored-narrative — I let an unusually satisfying physical-bottleneck chain carry the conviction score past what the relative-performance evidence supported).

And the same day handed me the structural reason it may stay that way. New York EO 62 (2026-07-14) is the first US statewide pause on ≥50 MW data-center permits — and the primary document says something the press does not: the widely-reported "one year" is not in the order, which runs "until DPS submits its report of the final Generic Environmental Impact Statement", i.e. unbounded. Siena poll: 46% good / 21% bad; a parallel legislative moratorium backstops it. PWR's demand leg needs projects to break ground. I had modelled interconnection queues, transformer lead times and FERC large-load policy — I had never modelled state environmental permitting as an independent, serial gate. New concept state-datacenter-siting-moratorium-risk is the cluster-level register (47% of chains are ai-infrastructure). Held honestly: no chain is downgraded on one state's order — grandfathering protects the in-flight pipeline and NY isn't where the marginal megawatt was going.

Net: 5 sources promoted + ingested, 1 net-new hypothesis (tungsten, thin vertical), 1 new concept, 2 new entities, 5 person-entities, 0 new mechanisms (3 strengthened, 2 explicitly not moved on price action), 1 contradiction recorded, 1 calibration.

Strongest-conviction buys

Ranked shortlist (4c). Prices 08-06 intraday, twelvedata. PWR drops out today — see Top of mind.

⚠ STVN promoted into the top 5 on today's evidence: the chain it rides was strengthened twice (LLY Q2 first-party + independent Bridge research), it is 5/5 confirmed, it trades −28% off highs, and it is the only healthcare name in the book with positive live sector-excess. ⚠ Near-misses: LIN (0.78) $491.05 (+1.3%) — high conviction, priced (−10.4% off hi). LLY (0.60) $1,169.86 (+4.9%) — the Q2 print rewarded, but only −6.4% off highs, and today's research shrank its headline catalyst (below). PWR (0.73) $682.99 (−1.4%) — chain intact, expression calibrated down.

Watchlist

Undervalued candidates (today)

• agentic-ai-seat-erosion-to-saas-rerate — NOW $117.22, −39.8% off high, FCF-positive; base $140–150.
• kazatomprom-supply-cut-to-western-uranium-premium — CCJ −30.3% off high. Note the live dispersion: same mechanism, NXE +9.1% and DNN +8.1% sector-excess vs UUUU −12.5%. The chain works; UUUU as its expression doesn't.
• glp1-injectable-supply-chain-bottleneck — STVN −28.2% off high on a 5/5-confirmed chain strengthened twice today.

New chains to investigate (hypothesis-stage)

• tungsten-export-controls-to-allied-primary-producer-rerate — ALM / KMT. China licensed only 15 tungsten exporters for 2026–27 and put APT on the dual-use list; Chinese APT exports −70% (782t→243t), Rotterdam APT <$400 → >$3,000/mtu (+200% YTD). The tape bought the toolmaker (kennametal +14.2% on 08-05) whose 41.1% GAAP margin is a disclosed $252M raw-material timing gap with FOCF −$79M — while almonty-industries' Sangdong entered commercial processing 2026-07-01. Today's tape supports the transitory read: KMT −5.3%. What it would take to graduate: Almonty's offtake / realized pricing — if concentrate is sold under a capped legacy offtake, every upstream step stays true and the thesis still fails. Do not graduate without it.

New theses (now active)

• None net-new as mechanisms. state-datacenter-siting-moratorium-risk is filed as an active concept but is a risk register, not a thesis — it names no tradeable of its own.

Updated theses (existing active)

• glp1-injectable-supply-chain-bottleneck — as_of→08-06. LLY Q2 first-party (+48% rev, $14.9B MOUNJARO/ZEPBOUND, US obesity scripts +78%) plus the CFO stating the per-unit-supplier thesis himself: US price −3%, CVS access "will drive... price to actually go down... we are going to more than offset that with volume growth." New: the Bridge formulary covers Zepbound as KwikPen only, routing volume into the pen layer (ypsomed) where "vials are more consistently available than KwikPens because Lilly's vial filling capacity expanded faster than autoinjector capacity." ⚠ Offset recorded, not buried: the new multi-dose KwikPen cuts pens-per-patient-month, and nothing nets the two — so "Bridge → pen squeeze" stays asserted, not confirmed.
• glp1-substitution-to-bariatric-surgery-decline — as_of→08-06. New step 5 (partial): retatrutide TRIUMPH-1/2/3, Skovronsky — "weight loss approaching bariatric surgery levels at the highest doses" — dated catalyst: US BLA submission Q1 2027 (with classification litigation as a schedule risk). Step 4 gains a fresh 2026 ASMBS volume series across three independent source types: 43k procedures (2023) → under 40k after declines in 2024 and 2025; +140% GLP-1 scripts vs −34% surgery 2022–24.
• phantom-data-center-load / ferc-large-load-to-dc-gridscale-construction — EO 62 corroborates the former (a permit moratorium mechanically manufactures phantom load) and adds a second serial gate to the latter (a favourable FERC ruling does not clear a state DEC permit).
• vera-cpu-to-arm-datacenter-royalty / tsmc-saturation-to-intel-anchor-stack — deliberately NOT moved. See below.

Contradicted / weakened

• pwr-transformer-moat-to-eps-doubling — /calibrate fired (the flywheel's first live-feedback calibration). Chain held; PWR as its expression marked down. See Top of mind.
• Contradiction recorded on glp1-injectable-supply-chain-bottleneck: Ricks cited "20 million eligible Americans" for the Medicare Bridge; CMS's own criteria yield "up to 3.8 million" — already this wiki's figure. Not reconciled away: both are attributable and measure different things (plan-enrolled vs clinically-eligible), but the wiki keeps 3.8M and flags the 20M as a ~5x denominator substitution that makes the catalyst look five times larger than it converts. Pattern: proxy mistaken for cause.
• The 08-05 ARM +17.4% / INTC +10.8% was flow, not a catalyst — question closed. Yesterday's dispatch deferred this. Every press explanation points at evidence already ingested here first-party: the "new" Intel figures ($16.13B / $0.42) are 2026-07-23-earnings-intc-q2-fy2026, from a call 12 days earlier; ARM's ">100% YoY datacenter royalty" is the Q1 FY2027 print of 07-29. What was new was sell-side (JPM/Needham PT $255) and sector beta (INTC +10 / AMD +8 / AVGO +6 on a +1.74% Nasdaq). No step status moved and no as_of advanced on a price move. Today's tape agrees: ARM −2.1%, INTC +0.2%.
• ⚠ New falsifier on vera-cpu-to-arm-datacenter-royalty: Needham flags smartphone unit-forecast cuts driven by memory costs — cross-linking memory-shock-to-oem-value-transfer / hbm-cowos-as-binding-bottleneck into ARM's other royalty pool, which the chain had never modelled. Status open (single sell-side source, secondhand).
• 4e gate: 23 live rows; 3 flags <−10% sector — PWR −10.7% (med-high → fired), UUUU −12.5% (medium 0.52 → no gate), TJX −11.6% (medium 0.40 → no gate, healed from −14.0%). 1 auto-calibration. Best live: AMZN +11.5%, NXE +9.1%, DNN +8.1%. Worst cluster: energy-oil −5.7% — consistent with today's tape (MPC −4.8%, XOP −3.9%, CVX −2.1%, VLO −2.1%).

Open questions worth a human's eye

• How long does a New York GEIS actually take? EO 62 ties the moratorium's end to a process with no statutory clock. A GEIS duration base rate would convert an open-ended risk into a dated one — the highest-value single follow-up in the book right now, because it prices the tail on 47% of the chains.
• What are Almonty's offtake terms? The whole tungsten thesis is one disclosure away from confirmed or dead, and every other step is already confirmed.
• SPCX −13.6% today — the largest single move in the book, on a cluster with three live chains (spacex-ipo-comp-anchor-to-space-peer-fade, spacex-ipo-passive-shortfall-to-equal-weight-rerate, spacex-placement-to-vol-tail-hedge). Un-researched this run — flagged for tomorrow, and deliberately not explained with an invented chain.
• Does a NY-style pause destroy load or merely relocate it to PJM/ERCOT/MISO? If it relocates, the cluster effect is ~zero and the trade is geographic, not directional.

What I looked at

• Run status: headless; steps 0.5–7 in-turn; price fetch paced 8/min — 51/51 priced, 0 429s. Weekly ledger (4d) not due. Per-concept bull/base/bear narratives carried forward (headless budget); load-bearing marks in the feed + tables.
• Breadth (2a): ai-infrastructure 47% ⚠ over (45 distinct chains) → net-new steered to thin verticals. Delivered: critical-minerals (tungsten hypothesis, +defence leg) and healthcare (LLY/GLP-1, which also promoted STVN into the top 5). The one ai-infra ingest was filed as risk, not as another beneficiary.
• Ingestion veins (0.5–0.7): podcast 0 — the vein is dark for a 2nd day, now doubly: AssemblyAI still returns "account balance is negative"; the documented Grok STT fallback also failed (403 — the XAI_API_KEY itself is dead, confirmed against /v1/models); Whisper benchmarked on this Pi at ~1.7× realtime (3:00 audio → 5:01 wall), so 3.7h of episodes ≈ 6h wall — not viable in-turn. 4 high-value episodes deferred (All-In/Saronic defence, Moonshots/Kratsios, Compound, Forward Guidance). Action for Paul: top up AssemblyAI or re-issue XAI_API_KEY — either restores it. Earnings 1 (LLY Q2; CEG/CF call today at 10:00/11:00 ET — not yet held; MP reports today). Feeds 0 (FK paywalled, SemiAnalysis "Kimi K3" off-scope, CP roundup).
• ⚠ PODCASTS.md filter gap (informational — the skill never edits it): Odd Lots published 11 new episodes, 0 kept. Three were squarely in scope: The Tungsten Market Is Warning of an Upcoming War, NY Governor Hochul on Her One Year Data Center Moratorium, Why Private Credit Got Entangled With Insurance. Both of today's best findings came from the first two, routed to autoresearch instead. Suggest adding data center, tungsten, private credit, insurance, defense, nuclear — or dropping the Odd Lots filter entirely per the file's own operator-asides rule.
• Sources: 5 promoted + 5 ingested → 2 entities + 5 person-entities + 1 concept + 1 hypothesis created; 0 new mechanisms, 3 strengthened, 2 explicitly held flat against a price move; 1 contradiction recorded; 1 calibration.
• prospect-chains: 1 auto-draft (tungsten); 1 candidate correctly dropped as a spine duplicate (Bridge→pen→WST is already glp1-injectable-supply-chain-bottleneck steps 4–5); 1 reclassified from thesis to falsifier (EO 62). 0 from the second-order / orphan-claim / question-graduation moves — wiki still well-connected.
• Signal feed (7): full active/armed set re-marked 08-06; as_of re-dated only for rows whose research moved (glp1-injectable ×3, glp1-bariatric, vera-cpu, ferc-large-load, pwr-transformer) — the rest carried forward.